The German economy is undergoing a period of upheaval. The automotive industry is
investing billions in developing new powertrain technologies and mobility services, while
manufacturing industries and mechanical engineering are becoming greener and more
sustainable. Following the phase-out of nuclear power, by 2038 brown coal will no longer be used
for electricity generation and priority is being given to developing renewable energy sources.
And importantly, digitalization is making its way into almost all areas of our lives. And as if all of this weren’t exciting enough, 2020 will go down in history as the year of the coronavirus pandemic. The virus is not only putting businesses and jobs at risk, it is also speeding up some development processes.
MEDICAL TECHNOLOGY AND PHARMACEUTICALS IN SAXONY-ANHALTTogether withits partners,IDT Biologikais developinga coronavirusvaccine.BIOPHARMAPARKDESSAUIN FIGURES:TOTAL AREA(HECTARES):120COMPANIESON SITE:5JOBS:2,200IDT and its research partners have receivedaround 114 million euros of funding for thephase I to III clinical trials and the applicationfor the approval of the virus. The Federal Ministryof Education and Research has provided atotal of 750 million euros to accelerate vaccinedevelopment and manufacturing in Germany.IDT Biologika is one of the three companiesworking on a vaccine that the German governmentis pinning its hopes on.As well as developing the virus asquickly as possible, it is also essential to makethe necessary production capacity available.Regardless of whether the efforts of IDTBiologika or one of the other companies leadsto the decisive breakthrough, the requirednumber of doses of the virus must be manufactured.“Here in central Germany, wehave the unique capabilityto cover the entire vaccinemanufacturing process fromresearch and developmentthrough to the filling and packagingof the vials. We need theproduction capacity not onlyto combat the coronavirus butalso to be ready for futurepandemics,”says Dr Jürgen Betzing, managing director ofIDT. The family business has spent a lot of itsown money to help overcome the challengesthe world is currently facing and to meet itsown standards of social responsibility.The biotech company IDT Biologika has a historythat dates back almost 100 years. Its rootsgo back to 1921 when scientists at the BakteriologischeInstitut der Anhaltischen Kreise (thebacteriological institute of the Anhalt region)were carrying out research into tuberculosis.They laid the foundations for the productionof human and animal vaccines. Nowadays IDTBiologika manufactures human vaccines onbehalf of companies all over the world. Thecompany currently has around 1500 employees.Since it was founded in 1993, IDT Biologikahas invested around 400 million euros in itsheadquarters at the BioPharmaPark in Dessau-Roßlau.idt-biologika.deThe development of vaccines inDessau dates back to 1921.A fertilesoilThe Weinberg CampusTechnology Park in Halle (Saale)is an innovation center for thelife sciences, biomedicine andmaterial sciences sectors incentral Germany.Familiar with the elements: Saxony-Anhalt’s Minister for Economy,Professor Dr Armin Willingmann,with the managing director of theTGZ Dr Ulf-Marten Schmieder.The terroir of a vineyard is known tohave a significant impact on the quality of thewine. At the Weinberg Campus in Halle (Saale),whose name means “vineyard” in German, thisprinciple also applies to research. The technologypark is the perfect combination of scienceand business and provides ideal conditions forthe research facilities, institutions and companiesbased there. The campus covers an area of134 hectares and more than 6000 people workthere in over 100 institutes and companies,making it the largest technology park in centralGermany. Biochemists, biotechnologists, materialscientists and pharmaceutical, agriculturaland nutrition scientists work side-by-side at theWeinberg Campus.A number of prominent institutes and societiesform the scientific basis for this work, includingthe Fraunhofer Institute for Microstructure ofMaterials and Systems, the Helmholtz Centerfor Environmental Research, the Leibniz Instituteof Plant Biochemistry and the Max PlanckInstitute of Microstructure Physics. In addition,the science faculties of Martin Luther UniversityHalle-Wittenberg and the university hospitalare both based on the campus.The Technology and Start-Up Center (TGZ)plays a key role on the Weinberg Campus. Itacts as the interface between applied research,development and production and supportsinnovative start-ups. More than 250 companieshave already been set up in the TGZ.3435